SCA
ARNA

Stonebridge Capital Advisors’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Stonebridge Capital Advisors’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-50
Closed -$5K – 1129
2021
Q4 		$5K Hold
50
– – ﹤0.01% 759
2021
Q3 		$3K Sell
50
-50
-50% -$2.95K ﹤0.01% 795
2021
Q2 		$6K Buy
100
+50
+100% +$3.26K ﹤0.01% 818
2021
Q1 		$3K Buy
+50
New +$3.85K ﹤0.01% 810
2020
Q3 		– Sell
-50
Closed -$3K – 776
2020
Q2 		$3K Hold
50
– – ﹤0.01% 643
2020
Q1 		$2K Sell
50
-360
-88% -$16.5K ﹤0.01% 678
2019
Q4 		$19K Sell
410
-50
-11% -$2.36K ﹤0.01% 457
2019
Q3 		$21K Hold
460
– – ﹤0.01% 439
2019
Q2 		$27K Buy
+460
New +$23.8K ﹤0.01% 413

Stonebridge Capital Advisors's ARNA Position: Q1 2022 in Review

Stonebridge Capital Advisors sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 50 shares — an estimated $5K sold.

Stonebridge Capital Advisors first reported a position in ARNA in Q2 2019 and held it in 9 quarters. The position peaked at $27K in Q2 2019. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • Stonebridge Capital Advisors reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Stonebridge Capital Advisors sold 50 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $5K.
  • Stonebridge Capital Advisors first reported a position in Arena Pharmaceuticals Inc in Q2 2019 and held it in 9 quarters.
  • Stonebridge Capital Advisors's Arena Pharmaceuticals Inc position peaked at $27K in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Stonebridge Capital Advisors's 13F filing for Q1 2022, filed 12 May 2022.